Page last updated: 2024-10-21

sk&f-38393 and Diabetic Glomerulosclerosis

sk&f-38393 has been researched along with Diabetic Glomerulosclerosis in 1 studies

2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine: A selective D1 dopamine receptor agonist used primarily as a research tool.
1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol : A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1 and two hydroxy substituents at positions 7 and 8.
SKF 38393 : A racemate comprising equimolar amounts of (R)- and (S)-SKF 38393

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barthelmebs, M1
Vailly, B1
Grima, M1
Velly, J1
Stephan, D1
Froehly, S1
Imbs, JL1

Other Studies

1 other study available for sk&f-38393 and Diabetic Glomerulosclerosis

ArticleYear
Effects of dopamine prodrugs and fenoldopam on glomerular hyperfiltration in streptozotocin-induced diabetes in rats.
    Journal of cardiovascular pharmacology, 1991, Volume: 18, Issue:2

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Carbidopa; Diabet

1991